Trial intelligence / Profile preview

Safety and PK of PA in Healthy Volunteers

NCT04174937Phase 1Completed

Sponsor
Scientific Center for Anti-Infectious Drugs
Start
Jun 2016
Primary completion
May 2019
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in respiratory tract infection (RTI) (2 arms), sponsored by Scientific Center for Anti-Infectious Drugs. Primary endpoint: Adverse Events up to 90 days. Started Jun 2016; status: completed.

02

Conditions

respiratory tract infection (RTI)

Beyond the preview

Go deeper on NCT04174937.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04174937.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call